Managing pharmaceutical supply chains across Latin America and the Caribbean (LAC) requires specialized expertise and a deep understanding of the region’s logistics, regulatory environments, and economic frameworks. The region presents a unique mix of infrastructure challenges, climate risks, trade policy dynamics, and security considerations. When these dynamics are not expertly managed, the consequences can include delayed access to essential medicines, loss of temperature‑sensitive products, compromised chain-of-custody controls, and ultimately, critical threats to patient safety.

🔒  Because of this, leading organizations are increasingly relying on regional experts who understand how to navigate these challenges while maintaining Good Distribution Practice (GDP) compliance, supply chain security, and reliable access to medicines. Leveraging experts to handle the following factors in Latin America and the Caribbean is a key tactic in pharmaceutical supply chain management.

1.  Infrastructure & Logistics

🚛  Latin America’s logistics networks—especially the ports, air cargo corridors, and cold‑chain infrastructure—are uniquely vulnerable to disruptions. Failure to properly manage these vulnerabilities can lead to shipment delays, product loss, and increased risk of compromised product integrity, each of which directly impacts patient safety.

Vulnerabilities include:

• Outdated or congested ports that slow API and finished‑drug movement
• High cargo‑theft risk, creating unpredictability and increased insurance costs
• Cold‑chain vulnerabilities, especially across multi‑modal routes
• Unreliable power grids, which threaten temperature‑controlled storage
• Complex customs procedures requiring real‑time local intelligence
• Dynamic transport routes that challenge cold‑chain capacity

Example: The Complex and Heavily Utilized Colombia>France>Chile Transport Route

Stage 1 — Colombia: Manufacturing or Sourcing Point

• Key LATAM pharmaceutical market with strong manufacturing & export capacity
• Requires strict handling, temperature control, and GDP compliance
• Pharmaceuticals are produced/consolidated in GMP-certified facilities
• Packed for cold-chain or non-cold-chain transport
• Shipped via Bogotá El Dorado Airport to Europe

Stage 2 — Paris (France): European Distribution Hub

• Major global pharmaceutical logistics hub (Paris CDG)
• Serves as EU compliance & quality control checkpoint
• Strong cold-chain infrastructure for temperature-sensitive products
• Used for consolidation before forwarding shipments to Chile
• Operations include relabeling, repackaging, and temperature stabilization

Stage 3 — Chile: Destination Market

• Rapidly modernizing healthcare market reliant on imported pharmaceuticals
• Rising demand for biologics & specialty drugs requiring cold-chain handling
• Customs processes follow strict GDP and local regulations
• Distributed to hospitals, pharmacies, and private distributors
• Chain-of-custody and temperature logs verified on arrival

2.  Climate & Environment

🌎  Extreme weather events across Latin America and the Caribbean have interfered with transportation corridors and energy availability, stressing pharmaceutical logistics and manufacturing operations. Climate‑related disruptions can cause delivery delays, complicate supply predictability, and compromise the cold chain.

Example: Hurricane Maria (Puerto Rico, 2017) continues to be cited in 2024–2025 research for causing severe pharmaceutical supply chain disruptions, including nationwide IV fluid shortages due to damage to key drug‑manufacturing facilities. (American Cancer Society)

3.  Politics Trade Policy, and Taxation

📑  Pharmaceutical supply chains across Latin America and the Caribbean must also navigate diverse regulatory environments, trade frameworks, and tax policies. Tariffs, import duties, customs valuation rules, and value‑added tax (VAT) structures can significantly influence how supply chains are designed and operated.

Companies often structure distribution routes, consolidation hubs, and packaging operations to manage customs duties and tax exposure while maintaining regulatory compliance and product integrity.

📑  Trade policy shifts can also alter supply chain economics quickly. Changes to tariff frameworks or import regulations in major economies may require companies to adjust routing strategies or modify distribution models to maintain efficient product flow without disrupting patient access to medicines.

🔒  Regional expertise is essential to balance tax efficiency with strict adherence to Good Distribution Practices, regulatory oversight, and supply chain security requirements. Without experienced professionals managing these dynamics, attempts to optimize duties or tax structures can unintentionally introduce operational risk.